2PQ-10027-84746
3 vaccinations
2 coded responses
17 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 450 / OH
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Pfizer-BioNTech
- 2021-03-19
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-25
- 2021-03-26
- 2021-04-04
-
2021-04-09
Dose 2 — Pfizer-BioNTech
- 2021-04-18
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
-
2021-10-08
Survey response — 6 months, dose 2MedDRA: Condition aggravated, Office visit, Pre-existing disease, Surgery — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Symptoms: I am having almost every LONG COVID issue that has been listed in the medical literature. Lung, Gastro, Reactivated Amyloidosis, Sevre Brain Fog, headaches, body pain and weakness, the list goes on · Healthcare visit (other): Surgery for Amyloidosis, EDG, Colonoscopy, Breathing Test, Heart test, continuing to go to evaluationsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2021-10-12
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-10-27
Dose 3 — Pfizer-BioNTech
-
2022-04-09
Survey response — 12 months, dose 2MedDRA: Condition aggravated, Gastrointestinal disorder, Lung disorder, Muscle disorder, Office visit, Physiotherapy, Pre-existing disease, Renal disorder, Speech-language therapy, Surgery — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Symptoms: Post COVID CLINIC at (b)(6) of (b)(6). All the long hauler symptoms. GI, Kidneys, Pulm, Muscular issues, reoccurance of AL Amyloid that had been in remission for 5 years. · Healthcare visit (other): Surgery, (b)(6) AMYLOID CLINIC, POST COVID CLINC UC, SPEECH, PULM, PELVIC, AND PHYSICAL REHABS,MedDRA releases: 2024-11 · check-in free text available
-
2022-04-09
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-04-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-09 | Pfizer-BioNTech | |
| 3 | 2021-10-27 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 10 — 6 months, dose 2
Symptoms: I am having almost every LONG COVID issue that has been listed in the medical literature. Lung, Gastro, Reactivated Amyloidosis, Sevre Brain Fog, headaches, body pain and weakness, the list goes on
Healthcare visit (other): Surgery for Amyloidosis, EDG, Colonoscopy, Breathing Test, Heart test, continuing to go to evaluations
Release 11 — 12 months, dose 2
Symptoms: Post COVID CLINIC at (b)(6) of (b)(6). All the long hauler symptoms. GI, Kidneys, Pulm, Muscular issues, reoccurance of AL Amyloid that had been in remission for 5 years.
Healthcare visit (other): Surgery, (b)(6) AMYLOID CLINIC, POST COVID CLINC UC, SPEECH, PULM, PELVIC, AND PHYSICAL REHABS,
redacted (b)(6)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Physiotherapy | · | · | ✓ |
| HCVO | Speech-language therapy | · | · | ✓ |
| HCVO | Surgery | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Lung disorder | · | · | ✓ |
| SD | Muscle disorder | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Renal disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release